Evidence map›Paper›PMID 27311911›Full record

ArticleBMJ open2016

Effectiveness of a pharmacist-led educational intervention to reduce the use of high-risk abbreviations in an acute care setting in Saudi Arabia: a quasi-experimental study.

Abdul Haseeb, Win Winit-Watjana, Abdul-Rahman R Bakhsh, Mahmoud E Elrggal, Muhammad Abdul Hadi, Alaa A Mously, Asmaa Z Gadibalban, Bashayir F Al-Ibraheem, Rasha A Almubark, Rawan A Ekram and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. "No BLT": The Rise and Risk of Acronyms in the Medical Record.HEC forum : an interdisciplinary journal on hospitals' ethical and legal issues · 2026
    Article
  3. Review
  4. Observational
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 3 countries.

Abdul HaseebDepartment of Clinical Pharmacy, College of Pharmacy, Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia.
Win Winit-WatjanaDepartment of Pharmacy Practice, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia.
Abdul-Rahman R BakhshAjyad Emergency Hospital, Ministry of Health, Makkah, Kingdom of Saudi Arabia.
Mahmoud E ElrggalDepartment of Clinical Pharmacy, College of Pharmacy, Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia Pharmaceutical research center, Deanship of Scientific research, Umm Al Qura University, Mecca, Kingdom of Saudi Arabia.
Muhammad Abdul HadiDepartment of Clinical Pharmacy, College of Pharmacy, Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia.
Alaa A MouslyPrince Sultan Military Medical City, Riyadh, Kingdom of Saudi Arabia.
Asmaa Z GadibalbanDepartment of Clinical Pharmacy, College of Pharmacy, Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia.
Bashayir F Al-IbraheemKing Faisal Specialist Hospital, Riyadh, Kingdom of Saudi Arabia.
Rasha A AlmubarkDepartment of Preventive Medicines, University of Tennessee Health Science Center, University of Tennessee, Memphis, United States.
Rawan A EkramDepartment of Clinical Pharmacy, College of Pharmacy, Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia.
Tahir Mehmood KhanSchool of Pharmacy, Monash University Malaysia, Selangor, Malaysia.
Umm al-Qura University · SAInternational Medical University · MYKing Faisal Specialist Hospital & Research Centre · SAMinistry of Health · SAMonash University Malaysia · MYRiyadh Armed Forces Hospital · SAUniversity of Tennessee Health Science Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo evaluate the effectiveness of a pharmacist-led educational intervention to reduce the use of high-risk abbreviations (HRAs) by healthcare professionals.

designQuasi-experimental study consisting of a single group before-and-after study design.

settingA public emergency hospital in Mecca, Saudi Arabia.

participants660 (preintervention) and then 498 (postintervention) handwritten physician orders, medication administration records (MRAs) and pharmacy dispensing sheets of 482 and 388 patients, respectively, from emergency wards, inpatient settings and the pharmacy department were reviewed.

interventionThe intervention consisted of a series of interactive lectures delivered by an experienced clinical pharmacist to all hospital staff members and dissemination of educational tools (flash cards, printed list of HRAs, awareness posters) designed in line with the recommendations of the Institute for Safe Medical Practices and the US Food and Drug Administration. The duration of intervention was from April to May 2011. MAIN OUTCOME: Reduction in the incidence of HRAs use from the preintervention to postintervention study period.

findingsThe five most common abbreviations recorded prior to the interventions were 'IJ for injection' (28.6%), 'SC for subcutaneous' (17.4%), drug name and dose running together (9.7%), 'OD for once daily' (5.8%) and 'D/C for discharge' (4.3%). The incidence of the use of HRAs was highest in discharge prescriptions and dispensing records (72.7%) followed by prescriptions from in-patient wards (47.3%). After the intervention, the overall incidence of HRA was significantly reduced by 52% (ie, 53.6% vs 25.5%; p=0.001). In addition, there was a statistically significant reduction in the incidence of HRAs across all three settings: the pharmacy department (72.7% vs 39.3%), inpatient settings (47.3% vs 23.3%) and emergency wards (40.9% vs 10.7%).

conclusionsPharmacist-led educational interventions can significantly reduce the use of HRAs by healthcare providers. Future research should investigate the long-term effectiveness of such educational interventions through a randomised controlled trial.

Indexed as

Abbreviations as TopicDrug PrescriptionsEducation, Medical, ContinuingEmergency Medical ServicesFemaleHealth PersonnelHospitals, PublicHumansInappropriate PrescribingInservice TrainingMaleMedication ErrorsPatient SafetyPharmaceutical PreparationsPharmacistsSaudi ArabiaPharmaceutical PreparationsClinical pharmacistEducational interventionHigh-risk abbreviationMedication errorPrescribing practices

Identifiers

PMID27311911
PMCPMC4916617
OpenAlexW2432905871

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.